150 related articles for article (PubMed ID: 8714262)
1. Proliferating cell nuclear antigen (PCNA) in non-Hodgkin's lymphomas: correlation with working formulation and Kiel classification in formalin-fixed paraffin-embedded material.
Rabenhorst SH; Burini RC; Schmitt FC
Pathology; 1996 Jan; 28(1):12-6. PubMed ID: 8714262
[TBL] [Abstract][Full Text] [Related]
2. A comparative assessment of proliferating cell nuclear antigen, c-myc p62, and nucleolar organizer region staining in non-Hodgkin's lymphomas: a histochemical and immunohistochemical study of 200 cases.
Korkolopoulou P; Patsouris E; Pangalis G; Tsenga A; Elemenoglou J; Thomas-Tsangli E; Spandidos D; Kittas C
Hum Pathol; 1993 Apr; 24(4):371-7. PubMed ID: 7684020
[TBL] [Abstract][Full Text] [Related]
3. Estimation of growth fraction in fine needle aspirates from non-Hodgkin's lymphoma using anti-proliferating cell nuclear antigen: correlation with the Kiel classification.
Schmitt FC; Rabenhorst SH; Maeda SA; Colturato V; Melo LN
Acta Cytol; 1996; 40(2):199-204. PubMed ID: 8629398
[TBL] [Abstract][Full Text] [Related]
4. Quantitative analysis of cellular proliferative activity in 35 T-cell non-Hodgkin's lymphomas. Use of proliferating cell nuclear antigen and Ki-67 (MIB-1) antibodies and nucleolar organizer regions.
Caulet-Maugendre S; Patey M; Granier E; Joundi A; Gentile A; Caulet T
Anal Quant Cytol Histol; 1996 Oct; 18(5):337-44. PubMed ID: 8908304
[TBL] [Abstract][Full Text] [Related]
5. MIB-1, Ki67, and PCNA scores and DNA flow cytometry in intermediate grade malignant lymphomas.
Pich A; Ponti R; Valente G; Chiusa L; Geuna M; Novero D; Palestro G
J Clin Pathol; 1994 Jan; 47(1):18-22. PubMed ID: 7907607
[TBL] [Abstract][Full Text] [Related]
6. p53, c-myc p62 and proliferating cell nuclear antigen (PCNA) expression in non-Hodgkin's lymphomas.
Korkolopoulou P; Oates J; Kittas C; Crocker J
J Clin Pathol; 1994 Jan; 47(1):9-14. PubMed ID: 7907610
[TBL] [Abstract][Full Text] [Related]
7. Growth fraction estimation of malignant lymphomas in formalin-fixed paraffin-embedded tissue using anti-PCNA/Cyclin 19A2. Correlation with Ki-67 labeling.
Kamel OW; LeBrun DP; Davis RE; Berry GJ; Warnke RA
Am J Pathol; 1991 Jun; 138(6):1471-7. PubMed ID: 1675840
[TBL] [Abstract][Full Text] [Related]
8. MIB1 (Ki-67) expression in non-Hodgkin's lymphomas.
Kalogeraki A; Tzardi M; Panagiotides I; Koutsoubi K; Bolioti S; Rontogianni D; Stefanaki K; Zois E; Karidi E; Darivianaki K; Delides G; Kanavaros P
Anticancer Res; 1997; 17(1A):487-91. PubMed ID: 9066700
[TBL] [Abstract][Full Text] [Related]
9. Proliferating cell nuclear antigen (PCNA) expression in childhood lymphomas.
Kalmanti M; Kanavaros P; Sakalidou A; Tzardi M; Datseris G; Bolonaki E; Kalmantis T; Kazlaris E; Delides G
Acta Morphol Hung; 1992; 40(1-4):215-21. PubMed ID: 1365765
[TBL] [Abstract][Full Text] [Related]
10. DNA image cytometry and the expression of proliferative markers (proliferating cell nuclear antigen and Ki67) in non-Hodgkin's lymphomas.
Czader M; Porwit A; Tani E; Ost A; Mazur J; Auer G
Mod Pathol; 1995 Jan; 8(1):51-8. PubMed ID: 7731942
[TBL] [Abstract][Full Text] [Related]
11. [Histological classification of malignant non-Hodgkin's lymphomas and patient survival: the Kiel classification versus the working formulation].
Nizze H; Bühring U
Verh Dtsch Ges Pathol; 1992; 76():110-6. PubMed ID: 1283239
[TBL] [Abstract][Full Text] [Related]
12. Growth fraction in centrocytic and follicular center cell lymphomas: assessment in paraffin sections with a proliferating cell nuclear antigen antibody and morphometric correlates.
Swerdlow SH; Westermann CD; Pelstring RJ; Saboorian MH; Williams ME
Hum Pathol; 1993 May; 24(5):540-6. PubMed ID: 7684024
[TBL] [Abstract][Full Text] [Related]
13. Comparison of S-phase fraction, working formulation, and Kiel classification in non-Hodgkin's lymphoma.
Joensuu H; Klemi PJ; Söderström KO; Jalkanen S
Cancer; 1991 Oct; 68(7):1564-71. PubMed ID: 1893358
[TBL] [Abstract][Full Text] [Related]
14. Growth fractions in canine non-Hodgkin's lymphomas as determined in situ by the expression of the Ki-67 antigen.
Fournel-Fleury C; Magnol JP; Chabanne L; Ghernati I; Marchal T; Bonnefond C; Bryon PA; Felman P
J Comp Pathol; 1997 Jul; 117(1):61-72. PubMed ID: 9263844
[TBL] [Abstract][Full Text] [Related]
15. Proliferative activity in non-Hodgkin's lymphomas. A comparison of the bromodeoxyuridine labeling index with PCNA immunostaining and quantitative image analysis.
Sebo TJ; Roche PC; Witzig TE; Kurtin PJ
Am J Clin Pathol; 1993 Jun; 99(6):668-72. PubMed ID: 8100680
[TBL] [Abstract][Full Text] [Related]
16. Proliferating cell nuclear antigen (PCNA) as a prognostic factor in non-Hodgkin's lymphoma.
Klemi PJ; Alanen K; Jalkanen S; Joensuu H
Br J Cancer; 1992 Oct; 66(4):739-43. PubMed ID: 1358164
[TBL] [Abstract][Full Text] [Related]
17. Modification of Kiel and working formulation classifications for improved survival prediction in non-Hodgkin's lymphoma.
Nabholtz JM; Friedman S; Collin F; Guerrin J
J Clin Oncol; 1987 Oct; 5(10):1634-9. PubMed ID: 3655861
[TBL] [Abstract][Full Text] [Related]
18. Biological heterogeneity of diffuse mixed small and large cell non-Hodgkin's lymphomas assessed by DNA flow cytometry and Ki67.
Palestro G; Pich A; Chiusa L; Geuna M; Ponti R; Kerim S; Novero D; Valente G
Leuk Lymphoma; 1995 Nov; 19(5-6):467-72. PubMed ID: 8590848
[TBL] [Abstract][Full Text] [Related]
19. Histologic subtypes and survival of Chinese patients with non-Hodgkin's lymphomas.
Liang R; Loke SL; Ho FC; Chiu E; Chan TK; Todd D
Cancer; 1990 Oct; 66(8):1850-5. PubMed ID: 2208041
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical detection of cell-cycle associated markers on paraffin embedded and formalin fixed needle biopsies of prostate cancer: correlation of p120 protein expression with AgNOR, PCNA/cyclin, Ki-67/MIB1 proliferation-scores and Gleason gradings.
Botticelli AR; Casali AM; Botticelli L; Zaffe D
Eur J Histochem; 1998; 42(1):41-8. PubMed ID: 9615190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
